Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 313

1.

The effect of tissue type-plasminogen activator deletion and associated fibrin(ogen) deposition on macrophage localization in peritoneal inflammation.

Cook AD, Vlahos R, Massa CM, Braine EL, Lenzo JC, Turner AL, Way KJ, Hamilton JA.

Thromb Haemost. 2006 Apr;95(4):659-67.

PMID:
16601837
2.

Influence of t-pA and u-PA on adipose tissue development in a murine model of diet-induced obesity.

Morange PE, Bastelica D, Bonzi MF, Van Hoef B, Collen D, Juhan-Vague I, Lijnen HR.

Thromb Haemost. 2002 Feb;87(2):306-10.

PMID:
11858492
3.
4.

Endogenous plasminogen activator expression after embolic focal cerebral ischemia in mice.

Ahn MY, Zhang ZG, Tsang W, Chopp M.

Brain Res. 1999 Aug 7;837(1-2):169-76.

PMID:
10433999
5.

Tissue-type plasminogen activator deficiency exacerbates arthritis.

Yang YH, Carmeliet P, Hamilton JA.

J Immunol. 2001 Jul 15;167(2):1047-52.

6.

Urokinase-type plasminogen activator and arthritis progression: role in systemic disease with immune complex involvement.

Cook AD, De Nardo CM, Braine EL, Turner AL, Vlahos R, Way KJ, Beckman SK, Lenzo JC, Hamilton JA.

Arthritis Res Ther. 2010;12(2):R37. doi: 10.1186/ar2946. Epub 2010 Mar 2.

7.

Urokinase but not tissue plasminogen activator mediates arterial neointima formation in mice.

Carmeliet P, Moons L, Herbert JM, Crawley J, Lupu F, Lijnen R, Collen D.

Circ Res. 1997 Nov;81(5):829-39.

8.

Differing roles for urokinase and tissue-type plasminogen activator in collagen-induced arthritis.

Cook AD, Braine EL, Campbell IK, Hamilton JA.

Am J Pathol. 2002 Mar;160(3):917-26.

9.

Plasminogen activators and inhibitors in peritoneal tissue.

Holmdahl L, Falkenberg M, Ivarsson ML, Risberg B.

APMIS. 1997 Jan;105(1):25-30.

PMID:
9063497
10.

Physiological consequences of loss of plasminogen activator gene function in mice.

Carmeliet P, Schoonjans L, Kieckens L, Ream B, Degen J, Bronson R, De Vos R, van den Oord JJ, Collen D, Mulligan RC.

Nature. 1994 Mar 31;368(6470):419-24.

PMID:
8133887
11.

Modulation of sympathetic activity by tissue plasminogen activator is independent of plasminogen and urokinase.

Schaefer U, Vorlova S, Machida T, Melchor JP, Strickland S, Levi R.

J Pharmacol Exp Ther. 2007 Jul;322(1):265-73. Epub 2007 Apr 11.

13.
14.

Biological effects of combined inactivation of plasminogen activator and plasminogen activator inhibitor-1 gene function in mice.

Lijnen HR, Moons L, Beelen V, Carmelie P, Collen D.

Thromb Haemost. 1995 Oct;74(4):1126-31.

PMID:
8560424
16.

The role of fibrinolysis in adhesion formation.

Holmdahl L.

Eur J Surg Suppl. 1997;(577):24-31. Review.

PMID:
9076449
17.
18.

Differential role of components of the fibrinolytic system in the formation and removal of thrombus induced by endothelial injury.

Matsuno H, Kozawa O, Niwa M, Ueshima S, Matsuo O, Collen D, Uematsu T.

Thromb Haemost. 1999 Apr;81(4):601-4.

PMID:
10235447
19.

Urokinase-type plasminogen activator contributes to heterogeneity of macrophages at the border of damaged site during liver repair in mice.

Kawao N, Nagai N, Tamura Y, Okada K, Yano M, Suzuki Y, Umemura K, Ueshima S, Matsuo O.

Thromb Haemost. 2011 May;105(5):892-900. doi: 10.1160/TH10-08-0516. Epub 2011 Feb 8.

PMID:
21301782
20.

Urokinase-type plasminogen activator and plasminogen mediate activation of macrophage phagocytosis during liver repair in vivo.

Kawao N, Nagai N, Tamura Y, Horiuchi Y, Okumoto K, Okada K, Suzuki Y, Umemura K, Yano M, Ueshima S, Kaji H, Matsuo O.

Thromb Haemost. 2012 Apr;107(4):749-59. doi: 10.1160/TH11-08-0567. Epub 2012 Feb 8.

PMID:
22318286

Supplemental Content

Support Center